Clinical Trial Update: Local Ablative Stereotactic Radiotherapy for Residual Hypermetabolic Lesion in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Long-term Responders to Immunotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating local ablative stereotactic radiotherapy for residual hypermetabolic lesions in locally advanced or metastatic non-small cell lung canc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Institut Cancerologie de l'Ouest | Conditions: Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer | Phase 3 | Status: UNKNOWN